VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

Stock Information for VSee Health Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About VSee Health Inc.

VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
VSee?Health Names Dr.?Milton?Chen?as?Chairman to Drive AI Infrastructure Growth
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.